Tag Archives: Schizophrenia

Brain tumors respond well to combo of radiation, schizophrenia drug

By Denise Heady Researchers at the UCLA Jonsson Comprehensive Cancer Center and colleagues have found that adding a drug once commonly used to treat schizophrenia to traditional radiation therapy helped improve overall survival in mice with glioblastoma, one of the deadliest and most difficult-to-treat brain tumors. The findings, published May 1 in Proceedings of the National Academy of Sciences,… Read More »

AstraZeneca sells European rights for schizophrenia drug to Cheplapharm

FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the New York Stock Exchange (NYSE) in New York, U.S., April 8, 2019. REUTERS/Brendan McDermid/File Photo (Reuters) – AstraZeneca Plc said on Wednesday it plans to sell the European and Russian rights for a schizophrenia drug to… Read More »

Schizophrenia risk gene linked to cognitive deficits in mice

Researchers have discovered in mice how one of the few genes definitively linked to schizophrenia, called SETD1A, likely confers risk for the illness. Mice genetically engineered to lack a functioning version of the enzyme-coding gene showed abnormalities in working memory, mimicking those commonly seen in schizophrenia patients. Restoring the gene’s function corrected the working memory… Read More »

FDA Approves Secuado (asenapine) Transdermal System for the Treatment of Adults with Schizophrenia

FDA Approves Secuado (asenapine) Transdermal System for the Treatment of Adults with Schizophrenia Print this page Miami, FL And Jersey City, NJ, October 15, 2019 — Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced the U.S. Food and Drug Administration (FDA) has approved Secuado (asenapine) transdermal system, the first-and-only transdermal patch… Read More »